Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Can a plant produce anti-SARS-CoV-2 antibody?

Cancer Vaccines: A Concoction Strategy to fight Leukemia

Ministry of AYUSH | Siddha Central Research Biotech Research Recruitment

Can a plant produce anti-SARS-CoV-2 antibody?
  • BiotechToday
  • World

Can a plant produce anti-SARS-CoV-2 antibody?

bioxone October 16, 2020October 15, 2020

Prama Ghosh, Amity University Kolkata

The current critical situation due to COVID–19 has resulted in excessive centralization of biomanufacturing capacities which is a matter of great concern. But on the brighter side, sharing of scientific data and information globally at an unprecedented speed has helped strengthen our ability in developing new solutions based on technology. Speaking of which, the manufacture of bioreagents specifically recombinant antibodies from plant bio-factories is being explored. 

For this purpose, the production of six different monoclonal antibodies against SARS-CoV-2 in Nicotiana benthamiana is tested in academic labs and a matter of weeks. For designing the antibodies, DNA sequence information was made rapidly available among other data sources by other groups in preprint publications. Engineered single-chain fragments of monoclonal antibodies were fused to a human gamma Fc which was transiently expressed using a viral vector. Recombinant SARS-CoV-2 N protein and its Receptor Binding Domain (RBD) in plants were produced simultaneously. These were further used to test the binding capacity of the antibodies. 

The results indicated that anti-SARS-CoV-2 monoclonal antibodies could be easily produced in gram amounts in a little more than 6 weeks by using N. benthamiana used as a production platform in repurposed greenhouses with little infrastructure requirements. With the help of similar procedures, diagnostic reagents can also be produced which will provide rapid therapeutic responses.

Also read: Cancer Vaccines: A Concoction Strategy to fight Leukemia

Reference: Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoors farms into biomanufacturing facilities, Borja Diego-Martin, Beatriz González, Marta Vazquez-Vilar, Sara Selma, Rubén Mateos-Fernández, Silvia Gianoglio, Asun Fernández-del-Carmen, Diego Orzaez, doi: https://doi.org/10.1101/2020.10.13.331306

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged a tobacco plant Antibody bio-factory bio-manufacture bioreagent COVID-19 human gamma monoclonal antibody Nicotiana benthamiana recombinant DNA recombinant DNA techniques recombinant protein SARS-CoV-2 vector viral vector

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Ministry of AYUSH | Siddha Central Research Biotech Research Recruitment

bioxone October 16, 2020

-Shristi Sharma, Team bioXone Siddha Central Research Jobs – Biotech & Mol Bio JRF Vacancy. MSc Biotechnology and Molecular Biology Job Openings. Junior Research Fellow Vacancy at Siddha Central Research Institute. Interested and eligible applicants can check out all of the details on the same below: Name of the Post: Junior Research Fellow(Pharmacology) No. of […]

Related Post

  • BiotechToday
  • World

Unravelling the gustatory receptors in cabbage butterflies

bioxone July 18, 2021July 17, 2021

Avani Dave, Jai Hind College On average, more than one-half of all the existing insect species are considered to be herbivorous, meaning, these insects feed on plants to derive nutrition, making them an essential contributor to the food chain. Despite their critical herbivorous nature, the terrestrial domain of our world is flourishing from the mossy […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Nano catalytic tumour therapy by single-atom catalysts

bioxone January 26, 2021January 26, 2021

Rohit Bhattacharjee, Amity University, Kolkata Recently, single‐atom catalysts (SACs) are receiving increasing attention in varied chemical process fields, and meantime, rising nano catalytic drugs provide a unique tumor therapy modality while not victimizing harmful chemo drugs. The distinct properties of SACs, like exactly situated metal centers, identical coordination setting, tailorable composition and structure, and versatile […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

COVID-19 vaccine for children: Pfizer shows progress!

BioTech Today November 22, 2021November 22, 2021

Ananya Ghosal, MAKAUT(WB) COVID-19 vaccine is still a dream for children under 12. Although children are not at risk of COVID-19 like adults, their reports are still positive. The delta variant and reopening of schools combined and resulted in a keen rise in pediatric COVID-19 cases that is related to the records in the pandemic. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy